CILODOC 100MG contains Cilostazol which belongs to a group of medicines called phosphodiesterase type 3 inhibitors. It has several actions which include widening of some blood vessels and reducing the clotting activity (clumping) of some blood cells called platelets inside your vessels. It is usually prescribed for intermittent claudication. Intermittent claudication is the cramp-like pain in your legs when you walk and is caused by insufficient blood supply in your legs.
Cilostazol helps in increasing the distance you can walk without pain since it improves the blood circulation in your legs. It is only recommended for patients whose symptoms have not improved sufficiently after making life-style modifications (such as stopping smoking and increasing exercise) and after other appropriate interventions. This medicine is not suitable for children and adolescents.
Cilostazol belongs to a class of medications called platelet-aggregation inhibitors (antiplatelet medications) which works by improving blood flow to the legs. It exerts its action by inhibiting phosphodiesterase activity and suppressing cAMP degradation. The inhibition of PDE3 allows for a rise in cAMP in platelets and blood vessels.
Always take CILODOC 100MG exactly as your doctor has directed you. It usually comes as a tablet to take by mouth. It is usually taken twice a day. It should be taken 30 minutes before breakfast and the evening meal. Follow the directions on the label before use.
Feeling sick (nausea) or indigestion:
Stick to simple meals and do not eat rich or spicy foods.
Headache:
Rest and drink plenty of fluids. Ask your doctor to recommend a painkiller.
Drowsiness or dizziness:
Get up and move around to feel awake, take small naps to edge off the sleepiness. Give your eyes a break to avoid fatigue and eat a healthy food to boost energy.
Diarrhoea:
Drink plenty of fluids to avoid dehydration. ORS should be used to prevent dehydration.
CILODOC 100MG is not recommended for use in pregnant women unless necessary. Discuss the risks and benefits with your doctor.
CILODOC 100MG is not recommended for use in breastfeeding women unless necessary. Discuss the risks and benefits with your doctor.
CILODOC 100MG may cause dizziness. Do not drive or handle any machines while taking this medicine.
CILODOC 100MG is not recommended in patients with severe kidney disease. Consult your doctor for advice.
CILODOC 100MG is not recommended in patients with severe liver disease. Consult your doctor for advice.
Do not take if you are allergic (hypersensitive) to Cilostazol or any other ingredients in this medicine.
CILODOC 100MG is not recommended in patients with severe heart disease. Consult your doctor for advice.
Tell your doctor, if you have a condition which increases your risk of bleeding or bruising, such as,
Tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or the following:
Drug | : | Cilostazol |
Pharmacological Category | : | Phosphodiesterase-3 Enzyme Inhibitor, Vasodilators |
Therapeutic Indication | : | Intermittent Claudication |
Dosage Forms | : | Tablet |
Store below 20-25°C and keep out of reach of children.
After how many days of taking CILODOC 100MG will I start feeling better?
The improvement is not seen immediately. Your symptoms may start improving after 2-4 weeks of starting the treatment. However, it may take about 12 weeks to notice the full benefits of the medicines.
Why is CILODOC 100MG considered harmful for heart failure patients?
It should not be given to heart failure patients of any severity because it may worsen heart failure further. Medicines having similar effect (phosphodiesterase inhibitor III) have decreased the lifespan of the patients, and therefore, it is an absolute no for heart failure patients.
Will CILODOC 100MG be more effective if taken in more than the recommended dose?
There is no need to take this medication more than its recommended doses. Taking an overdose of this medicine may trigger some side effects.
1.Michel T, Hoffman BB. Treatment of Myocardial Ischemia and Hypertension. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page - 765.
2. Zehnder JL. Drugs Used in Disorders of Coagulation. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page - 599.
3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 270.
4. Gersh BJ, Opie LH. Which Therapy for Which Condition? Inhibitors of the Renin-Angiotensin-Aldosterone System. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. Page - 528.
5. KD Tripathi MD. Anti-anginal and other anti-ischaemic drugs. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page - 555.
6. Yung-Wei Chi, Carl J Lavie, Richard V Milani and Christopher J White. Safety and efficacy of cilostazol in the management of intermittent claudication: Vascular health and management. Dec 2008; [Accessed on Dec 7, 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663440/
7. Mylan, Adamed Pharma S.A. Electronic Medicines Compendium (EMC) [Revised Feb 2020] [Accessed Dec 7 2020] https://www.medicines.org.uk/emc/files/pil.2609.pdf
8. Otsuka America pharmaceutical, inc. U.S. Food & Drug Administration [Accessed Dec 7 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020863s021lbl.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.